New SEC Form D filing
Plowshare Therapies LLC, 2026-08-31
A new SEC Form D private-offering notice from Lancaster, PA, a $6,651,390 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Gene therapy biotech developing treatments for rare pediatric genetic diseases, including a lead program for maple syrup urine disease.
Filed 2026-08-31Filed to raise $6,651,390First money in 2025-10-21Raised so far $6,651,390HQ (as filed) Lancaster, PASector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Late filing
Source linked the Form D on EDGAR↗Website verified plowsharetherapies.com↗Named in the filing 4 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Telemachus Therapeutics, Inc., 2026-09-02, $1.5M, Pittsburgh, PA
- Agen Genomics, Inc., 2026-09-02, $1.5M, Escondido, CA
- Gettysburg Cookie Company, LLC, 2026-09-02, Gettysburg, PA
- Sensible Biotechnologies, Inc., 2026-09-02, $15M, Oxford, Oxfordshire
- Perforated AI, Inc., 2026-09-01, $4M, Pittsburgh, PA
- Voxcell BioInnovation Inc., 2026-09-01, $2.2M, Victoria, BC, Canada
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.